NLSP and NCEL Related Headlines
Go Back- NewcelX adds Jeremy Shefner to advisory board
- NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
- NLS Pharmaceutics and Kadimastem complete merger as NewcelX
- NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
NLSP and NCEL Related Press Releases
Go Back- NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
- NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
NLSP and NCEL Related SEC Filings
Go Back- Form EFFECT NewcelX Ltd.
- Form EFFECT NewcelX Ltd.
- Form 6-K NewcelX Ltd. For: Nov 17
- Form SCHEDULE 13D NewcelX Ltd. Filed by: Revel Michel
- Form SCHEDULE 13D NewcelX Ltd. Filed by: Twito Ronen
- Form SCHEDULE 13G NewcelX Ltd. Filed by: League Jinn Sarl
- Form SCHEDULE 13G NewcelX Ltd. Filed by: CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP
- Form 6-K NewcelX Ltd. For: Nov 07
- Form POS AM NewcelX Ltd.
- Form SCHEDULE 13G/A NewcelX Ltd. Filed by: BIOTECHNOLOGY VALUE FUND L P
- Form 6-K NewcelX Ltd. For: Nov 04
- Form 6-K NewcelX Ltd. For: Nov 03

